Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (21)

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

2022

  1. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  2. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases

    Blood, Vol. 137, Núm. 25, pp. 3484-3494

  2. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Familial risk of developing atypical hemolytic-uremic syndrome

    Blood

2018

  1. Common and rare genetic variants of complement components in human disease

    Molecular Immunology, Vol. 102, pp. 42-57

2017

  1. Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

    Kidney International, Vol. 92, Núm. 4, pp. 953-963

2015

  1. Factor H-related proteins determine complement-activating surfaces

    Trends in Immunology, Vol. 36, Núm. 6, pp. 374-384

2013

  1. C3 glomerulopathy: Consensus report

    Kidney International

2010

  1. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

    The Lancet, Vol. 376, Núm. 9743, pp. 794-801

2009

  1. Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population

    Clinical and Experimental Immunology, Vol. 155, Núm. 1, pp. 59-64

2008

  1. Complement factor H binds to denatured rather than to native pentameric C-reactive protein

    Journal of Biological Chemistry, Vol. 283, Núm. 45, pp. 30451-30460

  2. Mutations in Proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome

    American Journal of Kidney Diseases, Vol. 52, Núm. 1, pp. 171-180

  3. Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor H

    Clinical and Experimental Immunology, Vol. 151, Núm. 1, pp. 1-13

2007

  1. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 1, pp. 240-245

  2. The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: Update and integration of membrane cofactor protein and factor I mutations with structural models

    Human Mutation, Vol. 28, Núm. 3, pp. 222-234

2006

  1. Insights into hemolytic uremic syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigree

    Molecular Immunology, Vol. 43, Núm. 11, pp. 1769-1775

2005

  1. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32

    Human Molecular Genetics, Vol. 14, Núm. 5, pp. 703-712

2004

  1. The human complement factor H: Functional roles, genetic variations and disease associations

    Molecular Immunology, Vol. 41, Núm. 4, pp. 355-367